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Objective: To determine levels of cholesterol lipoproteins and prevalence of dyslipidemias
in urban Asian Indians.
Methods: Population based 6123 subjects (men 3388) were evaluated. Mean1SD of various
cholesterol lipoproteins (total, HDL, LDL and non-HDL cholesterol) and triglycerides were
reported. Subjects were classified according to US National Cholesterol Education Program.
Results: Age-adjusted levels in men and women were cholesterol total 178.4  39 and
184.6  39, HDL 44.9  11 and 51.1  11, LDL 102.5  33 and 106.2  33, total:HDL 4.15  1.2
and 3.79  1.0 and triglycerides 162.5  83 and 143.7  83 mg/dl. Age-adjusted prevalence
(%) in men and women, respectively were, total cholesterol 200 mg/dl 25.1 and 24.9, LDL
cholesterol 130 mg/dl 16.3 and 15.1 and 100 mg/dl 49.5 and 49.7, HDL cholesterol <40/
<50 mg/dl 33.6 and 52.8, total:HDL cholesterol 4.5 29.4 and 16.8, and triglycerides
150 mg/dl 42.1 and 32.9%. Cholesterol level was significantly greater in subjects with
better socioeconomic status, body mass index and waist circumference while triglycerides
were more among those with high socioeconomic status, fat intake, body mass index and
waist circumference (p < 0.05). Hypercholesterolemia awareness (15.6%), treatment (7.2%)
and control (4.1%) were low.
Conclusions: Mean cholesterol and LDL cholesterol are low and triglycerides were high in
urban Asian Indians. Most prevalent dyslipidemias are borderline high LDL, low HDL and, rajeevgg@gmail.com (R. Gupta).
ciety of India. All rights reserved.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 8 0e2 8 8 281high triglycerides. Subjects with high socioeconomic status, high fat intake and greater
adiposity have higher total and LDL cholesterol and triglyceride and lower HDL cholesterol.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Lipid abnormalities, such as high total and low density lipo-
protein (LDL) cholesterol and low high density lipoprotein
(HDL) cholesterol, are the most important cardiovascular risk
factors.1 Prospective epidemiological studies in high and
middle income countries in Europe and North America have
consistently reported a direct and continuous association of
total and LDL cholesterol and inverse association of low HDL
cholesterol with coronary heart disease (CHD) morbidity and
mortality.1e3 Similar results have been reported in prospective
studies from Australasia and East Asia.4 No prospective
studies exist in low-income countries including India.5,6
INTERHEART caseecontrol study7 in 52 countries, including
many low income countries in Asia, Africa and South Amer-
ica, reported significant association of high apolipoprotein B
(apoB), total and LDL cholesterol, and total:HDL cholesterol
ratio and low apoA1 and HDL cholesterol with incident acute
myocardial infarction.8
Population-wide levels of various cholesterol lipoproteins
(total, LDL and HDL) and triglycerides as well as prevalence of
various dyslipidemias have been well reported from high and
middle-income countries.1,9 The US National Health and
Nutrition Evaluation Surveys periodically report population-
wide lipid levels.10,11 Mean population cholesterol levels
were 240 mg/dl in 1960’s and have declined to 202 mg/dl by
early 2010.10,11 Similar data have been reported from many
countries in Western Europe and Australasia.12 The Global
Burden of Chronic Diseases Risk Factor study reported mean
levels of total cholesterol and determined trends in 180
countries over a 35-year period from 1980 to 2005.13 It was
observed that total cholesterol levels were high in high and
middle income countries at baseline and declined signifi-
cantly over this period in high income countries and remained
unchanged in uppermiddle income countries. In lowermiddle
and low income countries total cholesterol levels were low
and there was an increase over this 35-year period.13 Only a
few large population based studies to determine mean popu-
lation cholesterol and cholesterol lipoprotein levels and
prevalence of hypercholesterolemia or other lipid abnormal-
ities have been performed in India. Previous studies have been
limited to local (a city) or regional (a particular state) levels.
The only multisite studies that reported lipid levels and
prevalence of various dyslipidemias were Indian Industrial
Population Study,14 and India Migration Study.15 Multisite
Indian Council of Medical Research Integrated Disease Sur-
veillance Project16 and Indian Women’s Health Study17 re-
ported prevalence of hypercholesterolemia only. We designed
the India Heart Watch to evaluate multiple cardiometabolic
risk factors in urban populations in India.6 Details of rationale
and methodology have been reported.6,18 The present studywas performed to assess population levels of total cholesterol,
LDL cholesterol, non-HDL cholesterol, HDL cholesterol and
triglycerides in urban men and women and to assess preva-
lence of various dyslipidemias. We evaluated lipid abnor-
malities among the urban middle class because it is the
biggest subset of Indian population.19,20 This group of appar-
ently homogenous subjects provides unique opportunity to
identify influence of lifestyles on cardiometabolic risk fac-
tors,19,21 including dyslipidemias. Study among this subset of
Indian population is also important because this segment of
more than 350 million subjects is poorly represented in pre-
vious national studies and majority of the Indians shall reside
in urban locations by middle of this century.222. Methods
Amultisite study to identify prevalence of cardiovascular risk
factors in urban populations in India was organized.6 Protocol
was approved by the institutional ethics committee of the
national coordinating center at Jaipur, India. Written
informed consent was obtained from all participants. Details
of methodology have been reported earlier.182.1. Sampling
Medium sized cities were identified in each of the large states
of India and investigators who had a track record of research
in cardiovascular or diabetes epidemiology were invited for
participation. 20 investigators were invited 15 agreed to
participate. The cities were in northern (Jammu, Chandigarh,
Karnal, Bikaner), western (Ahmadabad, Jaipur), eastern
(Lucknow, Patna, Dibrugarh), southern (Madurai, Hyderabad,
Belgaum) and central (Indore, Nagpur) regions of India. Four
investigators dropped out due to non-availability of technical
support and motivation and 11 investigators and their teams
finally performed surveys. An accredited national laboratory
(www.thyrocare.com) was identified and contracted for
collection and processing the blood samples at their national
center. Simple cluster sampling was performed at each site. A
middle-class location was identified at each city. This
depended upon themunicipal classification which is based on
reserve land price and is periodically developed by local gov-
ernment for taxation purposes. A sample size of about 250
men and 250 women (n ¼ 500) at each site is considered
adequate by World Health Organization to identify 20% dif-
ference in mean level of biophysical and biochemical risk
factors.21 We invited 800-1000 subjects in each location to
ensure participation of at least 500 subjects at each site esti-
mating a response of 70% as reported in previous studies.23 At
each site a uniform procedure for recruitment was followed.
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identified, houses were enumerated, number of subjects
20e75 years living in each house was determined, and all of
these individuals were invited to a local community center of
healthcare facility (clinic, dispensary) for examination and
blood collection. A reference home within each locality was
identified and every subsequent household was contacted
until the sample size was reached. This procedure ensured
participation of consecutive members of the locality and was
representative even if the survey was prematurely abandoned
at a particular location (e.g., Belgaum, Nagpur). This method
also ensured representativeness at sites where oversampling
was performed (e.g., Jaipur, Madurai). The surveys were pre-
ceded by meetings with community leaders to ensure good
participation. Subjects were invited in fasting state to a com-
munity/medical center within each locality either twice or
thrice a week depending upon the investigator’s schedule.
2.2. Data collection and measurements
The study case report form was filled by a research worker
from local investigators’ team after details were inquired from
the subject. Apart from demographic history, details of so-
cioeconomic status based on self-assessment, educational
status and occupational class were recorded. Smoking details
were inquired for type of smoking or non-smoked tobacco use,
number of cigarettes/bidis smoked and years of smoking or
tobacco use. Intake of alcohol was assessed as drink per week.
Qualitative method was used to assess dietary fat intake with
questions about type of cooking oil used and self-estimated
visible fat intake in g/day. Fruits and vegetables intake was
also assessed by a question that inquired number of helpings
(medium portions) of either fruits or green leafy vegetables.
Details of physical activity were assessed by questions for
exact daily duration (minutes) of work related, commute
related, or leisure time physical activity.
All the equipments for measurements of height, weight,
waist and hip size and blood pressure (BP) were similar at all
centers for ensuring uniformity. Physical examination empha-
sized measurement of height using stadiometer, weight using
calibrated spring weighing machines, waist and hip were
measured using tapes and sitting BP measured after at least
5 min rest using electronic instruments.21 Three readings were
obtained and averaged for analysis. Fasting blood sample was
obtained fromall individuals after 8e10 h fasting. Sampleswere
collected at community centers by technicians from the local
unit of the accredited national laboratory, Thyrocare Technol-
ogies Ltd (www.thyrocare.com).24 Blood glucose was measured
at the local biochemistry facility of these laboratories andserum
transported in dry-ice to the national referral laboratory at
Mumbai (India) where a uniform protocol was used for mea-
surements. Total cholesterol, HDL cholesterol and triglyceride
levelsweremeasured using enzyme-based assayswith internal
and external quality control as reported earlier.18 Values of LDL
cholesterol and ratio of total:HDL cholesterol were calculated.18
2.3. Diagnostic criteria
High total cholesterol was defined as 200 mg/dl, high LDL
cholesterol as 130 mg/dl, high non-HDL cholesterol as160 mg/dl, low HDL cholesterol <40 mg/dl in men and
<50 mg/dl in women and high triglycerides 150 mg/dl.25
Ideal LDL cholesterol was defined as <100 mg/dl.26 High
total:HDL cholesterol was defined as 4.5 according to a pre-
vious Indian study.14 Overweight or obesity was defined as
body mass index (BMI) 25 kg/m2 and truncal obesity was
diagnosed when waist:hip ratio was >0.9 in men and >0.8 in
women.27 It was also defined as waist circumference was
>90 cm in men and >80 cm in women according to the
harmonized guidelines of NCEP.28 Hypertension was diag-
nosed when systolic BP was 140 mm Hg and/or diastolic
BP  90 mm Hg or a person was a known hypertensive. Dia-
betes was diagnosed on the basis of either history of known
diabetes or fasting glucose 126 mg/dl. Metabolic syndrome
was diagnosed according to the harmonized NCEP definition
for Asian Indians.28 Socioeconomic status was categorized
according to education, occupation and socioeconomic
scale.18 Smokers included subjects who smoked cigarettes,
bidis, or other smoked forms of tobacco daily, past smokers
were subjects who had smoked for at least 1 year and had
stoppedmore than a year ago. Users of other forms of tobacco
(nasal, oral, etc) were classified as non-smoked tobacco use.
The diagnostic criteria for tobacco use as well as other coro-
nary risk factors have been advised by the World Health Or-
ganization.21 Subjects consuming more than 20 g visible fat
daily were categorized as high fat intake and those consuming
2 servings of fruits or vegetables daily as low intake.18 Those
involved in moderate degree of work or leisure time related
physical activity were classified as active and others as not
active, as in earlier studies.18
2.4. Statistical analyses
All the case-report form data in the study were entered into a
database (SPSS V13.0, SPSS Inc, Chicago). Values for men and
women have been analyzed separately. Numerical variables
are reported as mean  1 SD and categorical variables as
percent. Age-adjustment was performed using direct method
with 2001 Indian census population as standard. In subjects
with various cholesterol lipoprotein abnormalities, intergroup
comparisons in risk factors were performed using X2 test and
means compared using unpaired t-test or ANOVA as appro-
priate. Intergroup trends were calculated using Mantel-
Haenszel X2 test for trend for categorical variables. p < 0.05
was considered significant.3. Results
The study was performed at eleven cities located in all regions
of India. 6198 subjects of the targeted 9900 subjects were
recruited (response 62%). Details of lipid levels were available
in 6123 subjects (men 3388, women 2735). Social and de-
mographic characteristics in men and women have been
previously reported.18 Men were slightly older than women.
Low educational status (illiteracy and <10 years of formal
education) was more among women (47.6%) as compared to
men (22.3%). Majority of subjects belonged to middle socio-
economic status. More than half of all men and women lived
in joint families and 85.6% were married. 17% subjects had
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cardiovascular risk factors has been reported.18
Mean cholesterol lipoproteins and triglycerides levels in
different age-groups are shown in Table 1. Age-adjusted
levels, in men and women respectively, were total choles-
terol 178.4  39 and 184.6  39 mg/dl, LDL cholesterol
102.5  33 and 106.2  33 mg/dl, non-HDL cholesterol
134.7  37 and 135.0  37 mg/dl, HDL cholesterol 44.9  11 and
51.1  11 mg/dl, total:HDL cholesterol 4.15  1.22 and
3.79  1.04 and triglycerides 162.5  83 and 143.7  83 mg/dl.
Age-group associated trends in mean levels of total, LDL and
HDL cholesterol and triglycerides are shown in Fig. 1. There is
significant increase in total and LDL cholesterol (ANOVA
trend, p< 0.001),more inwomen thanmen. Triglyceride levels
are greater in younger men as compared to women with a
significant age-associated increase. Mean HDL cholesterol
levels are greater in women as compared to men but no sig-
nificant age-related trend is observed.
Age-specific prevalence of various dyslipidemias is shown
in Table 2. There is age-associated increase in prevalence of
high total, LDL and non-HDL cholesterol (Mantel-Haenszl X2,
ptrend < 0.05). Age-adjusted prevalence of high cholesterol
(200 mg/dl) was 25.0% (men 24.8%, women 25.3%), high LDLTable 1 e Age-specific mean levels of various cholesterol lipop
Cholesterol lipoproteins, triglycerides (mg/dl) Ag
Total cholesterol (Men 3388, women 2735)
HDL cholesterol (Men 3385, women 2735)
LDL cholesterol (Men 3378, women 2733)
Non-HDL cholesterol (Men 3385, women 2735)
Triglycerides (Men 3382, women 2733)
Total:HDL cholesterol (Men 3368, women 2731)cholesterol (130 mg/dl) in 15.8% (men 16.3%, women 15.1%),
high non-HDL cholesterol (160 mg/dl) in 18.8% (men 20.9%,
women 16.2%), high total:HDL cholesterol ratio (>4.5) in 23.8%
(men 29.4%, women 16.8%), high triglycerides (150 mg/dl) in
36.9% (men 41.2%, women 31.5%), and low HDL cholesterol in
42.5% (men 34.1%, women 53.0%). Age adjusted prevalence of
atherogenic dyslipidemia29 defined by LDL cholesterol
100 mg/dl, triglycerides 150 mg/dl and HDL cholesterol
<40 mg/dl men and <50 mg/dl women was in 7.8% (men 7.0%,
women 8.9%).
We also determined mean levels of various cholesterol li-
poproteins and triglycerides in various sociodemographic and
anthropometric groups (Table 3). Total cholesterol levels were
greater in high (compared to low) socioeconomic status (men
4.8%, women 3.3%), educational status (men 2.5%, women
1.2%), body mass index (men 7.5%, women 2.6%) and waist
size (men 5.5%, women 3.4%) subjects (p < 0.05). Similar as-
sociations were observed for LDL and non-HDL cholesterol
(Table 3). Triglyceride levels were more in subjects with
smoking/tobacco use (men 7.3%, women 6.3%), high fat intake
(men 9.4%, women 1.3%) and high waist size (men 10.1%,
women 15.8%); while significantly lower HDL cholesterol
levels were observed in subjects with high body mass indexroteins in men and women.
e-group Men Women
<30 163.7  40.3 160.5  31.4
30e39 177.3  38.3 174.3  32.9
40e49 184.0  36.4 185.7  36.0
50e59 183.8  40.9 192.4  39.0
60e69 178.6  42.1 197.5  43.4
70þ 179.2  43.3 199.3  42.8
<30 43.7  10.2 47.9  11.3
30e39 43.0  9.5 48.9  11.1
40e49 44.4  9.7 50.6  11.4
50e59 45.5  10.5 51.1  12.0
60e69 46.9  11.0 53.5  13.2
70þ 47.8  9.6 57.0  13.0
<30 93.8  33.6 89.7  26.0
30e39 100.9  31.0 99.2  27.4
40e49 104.6  31.0 106.3  29.9
50e59 106.3  34.8 110.0  33.4
60e69 100.6  34.9 113.5  36.9
70þ 102.0  35.6 113.3  37.8
<30 120.0  37.0 112.6  30.2
30e39 134.2  36.4 125.4  31.6
40e49 139.7  34.2 135.4  33.9
50e59 138.3  39.0 141.3  37.1
60-69 131.5  39.9 144.0  40.5
70þ 131.3  42.0 142.3  40.3
<30 130.5  89.9 114.3  57.7
30e39 167.5  93.7 130.7  68.5
40e49 178.1  93.9 144.7  67.2
50e59 162.4  88.4 156.0  86.1
60e69 155.6  89.6 152.6  64.7
70þ 146.5  78.5 145.2  53.7
<30 3.9  1.2 3.5  0.9
30e39 4.2  1.1 3.7  0.9
40e49 4.3  1.2 3.8  1.0
50e59 4.2  1.2 3.9  1.1
60e69 4.0  1.2 3.8  1.1
70þ 3.9  1.2 3.6  0.9
150
160
170
180
190
200
210
220
<30 30-39 40-49 50-59 60-69 70+
Men Women
80
90
100
110
120
130
<30 30-39 40-49 50-59 60-69 70+
Men Women
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<30 30-39 40-49 50-59 60-69 70+
Men Women
30
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70
<30 30-39 40-49 50-59 60-69 70+
Men Women
Total cholesterol
Triglycerides HDL cholesterol
LDL cholesterol
Fig. 1 e Age-group specific levels of total cholesterol, LDL cholesterol, triglycerides and HDL cholesterol (mg/dl). There is
significant age-associated increase in total and LDL cholesterol (ANOVA trend, p< 0.001), more in women than men.
Triglyceride levels are greater in younger men as compared to women with a significant age-associated increase. No
significant trend is observed in HDL cholesterol levels.
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women 2.6%) (p < 0.05).
There was a low awareness and control of borderline and
high total cholesterol among the study subjects (Figs. 1 and 2).
Awareness was in 17.5% men and 13.2% women with high
cholesterol, treatment with statins was in 7.5% men and 6.7%
women, while control to targets of total cholesterol <200 mg/
dl was in 4.5% men and 3.7% women.4. Discussion
There are only a few studies that evaluated mean levels of
various cholesterol lipoproteins and prevalence of various dys-
lipidemias in India.6 A review reported that among adults, in
urban and rural areas respectively, the total cholesterol levels
varied from158 to248mg/dland166e182mg/dl, LDLcholesterol
70e120 mg/dl and 97e120 mg/dl, HDL cholesterol 35e54 mg/dl
and 39e50 mg/dl, and triglycerides from 80 to 168 and
124e151 mg/dl.30 Prevalence of various types of dyslipidemias
ranged from10 to 73%. However, these studieswere confined to
one or two centers and not comparable to the present study.
There are only a few multicentric studies in India which used
common protocol for laboratory assessment similar to the pre-
sent study. The Indian Industrial Surveillance Study evaluated
various lipid abnormalities among male industrial workers in
different regions of the country.14 India Migration Study15 eval-
uated lipid levels only among the rural subjects while in the
multisite Integrated Disease Surveillance Project of Indian
Council of Medical Research16 only total cholesterol levels were
measured. Multisite Indian Women’s Health Study17 also eval-
uated total cholesterol levels only. All these studies reported a
low prevalence of hypercholesterolemia, which is similar to thepresent study. The Indian Industrial Surveillance Study13 and
India Migration Study15 reported that prevalence of low HDL
cholesterol, hypertriglyceridemiaand total:HDLcholesterolwas
higher thanhypercholesterolemia. These findings are similar to
the present study and show that various components of
atherogenic dyslipidemia may be the more important lipid
phenotype in Asian Indians. These risk factors are important
components of the metabolic syndrome, which is highly prev-
alent in India.31
This is the first study, which has collected cross-sectional
data across the Indian urban population. It shows that mean
levels of total cholesterol, LDL cholesterol and non-HDL
cholesterol are lower in urban Asian Indian middle-class
subjects than in populations in high income countries as re-
ported in the Global Burden of Diseases Study.13 Triglycerides
levels in these subjects are greater and HDL cholesterol levels
lower. Components of atherogenic dyslipidemia (borderline
high LDL cholesterol, low HDL cholesterol, hyper-
triglyceridemia)29 are the most prevalent lipid abnormalities.
Levels of lipoprotein lipids are greater in subjects with high
socioeconomic status and education, high BMI and high waist
size. There is a low status of awareness, treatment and control
of hypercholesterolemia. We also studied levels of cholesterol
lipoproteins in various subgroups (Table 3). Cholesterol, LDL
cholesterol and triglyceride levels were greater in subjects
with higher socioeconomic status and more education. These
findings are similar to previous studies from India.32 We could
not find any significant difference in various cholesterol li-
poprotein levels with dietary intake of visible fats, fruits,
vegetables, physical activity or smoking/tobacco use. This
could be due to limitations of the qualitative questionnaire
that we used. On the other hand, cholesterol, its lipoproteins
and triglyceridesweremore andHDL cholesterol lower among
Table 2 e Age-specific prevalence of dyslipidemias.
Age-group Number of
men/women
Men
(n ¼ 3388)
Women
(n ¼ 2735)
Total cholesterol: 200 mg/dl <30 253/204 47 (18.6) 20 (9.8)
30e39 570/565 136 (23.8) 113 (20.2)
40e49 899/777 279 (31.0) 264 (33.9)
50e59 869/626 286 (32.9) 255 (40.7)
60e69 532/443 167 (31.4) 207(46.7)
70þ 265/122 73 (27.5) 61 (50.0)
X2 for trend (p value) <0.001 <0.001
HDL cholesterol: men<40 mg/dl;
women<50 mg/dl
<30 253/204 88 (34.8) 127 (62.2)
30e39 569/565 230 (40.4) 325 (57.5)
40e49 899/776 298 (33.1) 380 (48.9)
50e59 868/626 268 (30.9) 291 (46.5)
60e69 531/443 131 (24.7) 176 (39.7)
70þ 265/122 50 (18.8) 35 (28.7)
X2 for trend (p value) <0.001 <0.001
LDL cholesterol 130 mg/dl <30 253/204 32 (12.6) 12 (5.9)
30e39 568/564 93 (16.4) 62 (11.0)
40e49 899/776 175 (19.5) 149 (19.2)
50e59 868/626 196 (22.6) 156 (24.9)
60e69 531/443 93 (17.6) 143 (32.3)
70þ 265/122 48 (18.1) 43 (35.2)
X2 for trend (p value) 0.054 <0.001
Non-HDL cholesterol 160 mg/dl <30 253/204 41 (16.2) 11 (5.4)
30e39 569/565 124 (21.8) 64 (11.3)
40e49 899/775 232 (25.8) 163 (21.0)
50e59 868/626 232 (26.7) 181 (28.9)
60e69 531/443 113 (21.3) 146 (32.9)
70þ 265/122 58 (21.9) 42 (34.4)
X2 for trend (p value) 0.280 <0.001
Triglycerides 150 mg/dl <30 253/204 77 (30.4) 46 (22.5)
30e39 569/564 260 (45.7) 160 (28.3)
40e49 899/774 480 (53.4) 307 (39.7)
50e59 867/626 391 (45.1) 275 (43.9)
60e69 529/443 211 (39.9) 194 (43.8)
70þ 265/122 98 (37.0) 46 (37.7)
X2 for trend (p value) 0.250 <0.001
Total:HDL cholesterol 4.5 <30 253/204 58 (22.9) 26 (12.7)
30e39 568/564 194 (34.1) 98 (17.4)
40e49 899/774 307 (34.1) 142 (18.3)
50e59 865/626 294 (34.0) 137 (21.9)
60e69 529/443 136 (25.7) 95 (21.4)
70þ 265/122 59 (22.2) 16 (13.1)
X2 for trend (p value) 0.033 0.036
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similar to previous Indian and international studies.9
In contrast to India, population based studies of mean
levels of cholesterol and other lipoproteins are available from
USA and most high and upper-middle income countries. The
US National Health Evaluation Studies (NHES) and National
Health and Nutritional Evaluation Studies (NHANES) have
periodically reported mean levels of total cholesterol and
other cholesterol lipoproteins from mid 20th century.10 Mean
cholesterol levels were 222 mg/dl in early 1960’s, which
decreased to 203 mg/dl in the year 2002.10 Mean LDL choles-
terol levels were 129 mg/dl in 1988e1994 and 123 mg/dl in
2002. The mean HDL cholesterol levels in 1976 and 2002 were
45 and 46 mg/dl in men and 54 and 56 mg/dl in women while
mean triglyceride levels were 114 mg/dl in 1976 and 122 mg/dl
in 2002.10 Total cholesterol levels have further declined to
196 mg/dl in 2010.11 In the international MultinationalMonitoring of Trends and Determinants in Cardiovascular
Disease (MONICA) study in 21 countries on 4 continents, the
mean total cholesterol levels of adults (35e64 years) were
similar to the US populations and significantly greater than in
the present study.33 Global Burden of Chronic Diseases Risk
Factors study has reportedmean level of total cholesterol in 24
high income and 66 middle and low-income countries.13
Fasting total cholesterol concentrations were the highest in
high-income countries in years 1980 and 2008 (217 and
202 mg/dl respectively), intermediate in middle income
countries (190 and 182 mg/dl) and the lowest in low-income
countries (172 and 162 mg/dl). In the present study the age-
adjusted total cholesterol levels in men and women are
178  39 and 185  39 mg/dl. These values are similar to those
in middle income countries.
In China, He et al evaluated 15,540 men and women 35e74
years old in a nationally representative study,34 24% subjects
Table 3eAge-adjustedmean and 95% confidence intervals (mg/dl) of cholesterol lipoproteins and triglycerides in various socio-demographic and anthropometric groups.
Men Women
Total cholesterol HDL cholesterol LDL cholesterol Triglyceride Total cholesterol HDL cholesterol LDL cholesterol Triglyceride
Socioeconomic status
Low 174.0 (168.6e179.6) 44.2 (42.8e45.5) 99.7 (95.0e104.2) 151.3 (139.2e163.4) 179.0 (173.8e186.0) 50.0 (48.1e51.9) 103.7 (98.6e108.9) 130.7 (119.5e141.1)
Medium 178.7 (176.9e180.5) 45.1 (44.6e45.5) 101.3 (99.8e102.8) 164.3 (160.4e168.2) 186.5 (184.7e188.3) 50.7 (50.2e51.3) 106.4 (104.9e107.9) 147.0 (143.7e150.3)
High 182.4 (179.3e185.4) 44.7 (44.0e45.5) 106.2 (103.6e108.7) 157.3 (150.6e163.9) 184.9 (181.3e188.5) 51.4 (50.3e52.5) 105.7 (102.7e108.7) 137.9 (131.4e144.5)
p value (ANOVA) 0.016 0.316 0.002 0.046 0.137 0.550 0.606 0.002
Education level
0-10 years 176.7 (173.0e180.5) 43.9 (42.9e44.8) 101.3 (98.2e104.5) 158.6 (150.1e167.0) 184.1 (181.5e186.7) 49.1 (48.2e49.9) 105.9 (103.7e108.1) 145.4 (140.8e150.0)
11-15 years 180.0 (178.2e181.9) 45.3 (44.8e45.8) 102.9 (101.4e104.5) 161.8 (157.6e166.0) 186.0 (183.9e188.1) 52.5 (51.8e53.2) 105.1 (103.3e106.9) 142.3 (138.5e146.0)
>15 years 181.1(178.6e183.6) 45.7(45.0e46.3) 102.8(100.7e104.8) 163.5(157.8e169.1) 186.4(182.6e190.1) 52.7(51.5e53.9) 107.3(104.1e110.4) 131.2(124.5e137.9)
p value (ANOVA) 0.232 0.031 0.772 0.595 0.576 <0.001 0.185 <0.001
Visible fat intake
<20 g/day 178.1 (175.1e181.0) 44.4 (43.6e45.1) 103.5(101.2e105.9) 154.0 (147.7e160.3) 184.2 (181.5e186.8) 49.4 (48.6e50.3) 106.8 (104.6e109.0) 140.6 (135.6e145.6)
20e40 g/day 181.7 (179.6e183.8) 44.9 (44.3e45.4) 103.6 (101.8e105.8) 167.0 (162.2e171.6) 186.4 (184.1e188.6) 50.7 (50.0e51.4) 105.9 (104.0e107.8) 148.2 (143.9e152.4)
>40 g/day 181.1 (177.6e184.8) 44.1 (43.1e45.0) 103.6 (100.6e106.6) 168.4 (160.4e176.4) 187.4 (183.3e191.3) 50.1 (48.9e51.4) 108.7 (105.3e112.1) 142.4 (134.8e150.0)
p value (ANOVA) 0.105 0.116 0.985 0.003 0.103 0.017 0.535 0.024
Fruit/Vegetable intake
2 servings/day 179.8 (178.1e181.5) 44.7 (44.3e45.1) 102.8 (101.4e104.2) 163.1 (159.2e166.9) 185.3 (183.4e187.0) 50.4 (49.8e50.9) 106.7 (105.3e108.2) 141.0 (137.8e144.3)
3e4 servings/day 180.4 (177.4e183.5) 46.1 (45.3e46.8) 102.8 (100.2e105.3) 158.8 (151.9e165.6) 184.3 (180.9e187.7) 51.3 (50.2e52.3) 104.3 (101.5107.1) 143.5 (137.2e149.8)
>5 servings/day 179.7 (173.8e185.7) 44.5 (43.0e46.0) 101.7 (96.7e106.6) 171.2 (157.7e184.6) 189.0 (181.5e196.7) 49.8 (47.5e52.5) 104.4 (98.0e110.9) 173.8 (159.6e187.9)
p value (ANOVA) 0.959 0.012 0.892 0.248 0.331 0.398 0.203 <0.001
Smoking/tobacco use
Non user 179.9 (178.3e181.5) 45.2 (44.8e45.6) 103.1 (101.7e104.4) 158.8 (155.2e162.4) 185.3 (183.8e186.7) 51.2 (50.7e51.6) 105.5 (104.3e106.8) 143.0 (140.1e145.8)
User 179.5 (177.0e182.1) 44.7 (44.0e45.3) 101.6 (99.5e103.8) 170.4 (164.7e176.1) 185.2 (180.6e189.8) 48.0 (46.6e49.5) 106.8 (102.9e110.6) 152.0 (143.2e160.8)
p value (ANOVA) 0.835 0.126 0.275 0.001 0.679 <0.001 0.368 0.035
Body mass index categories
<23 kg/m2 170.9 (168.5e173.5) 45.9 (45.2e46.5) 96.8 (94.7e98.9) 141.6 (138.0e147.2) 181.6 (178.9e184.2) 51.4 (50.6e52.3) 103.8 (101.5e106.0) 132.2 (127.2e137.2)
23e24.9 kg/m2 183.3 (180.5e186.2) 45.1 (44.4e45.8) 105.1 (102.7e107.5) 167.1 (160.8e173.4) 185.2 (181.8e188.5) 51.5 (50.5e52.6) 105.6 (102.8e108.5) 139.8 (133.4e146.1)
25e29.9 kg/m2 184.3 (182.2e186.5) 44.6 (44.0e45)0.1 106.0 (104.2e107.8) 171.8 (166.9e176.6) 188.4 (186.0e190.7) 50.7(49.9e51.4) 108.3 (106.3e110.3) 147.3 (142.8e151.7)
30 kg/m2 183.8(179.5e188.1) 44.1(43.0e45.2) 104.7(101.0e108.2) 173.3(163.7e182.9) 186.3 (183.0e189.6) 49.7 (48.6e50.7) 106.0 (103.3e108.8) 152.8 (146.6e159.0)
p value (ANOVA) <0.001 0.035 <0.001 <0.001 <0.001 0.312 <0.001 <0.001
Waist circumference categories
<90/80 cm 175.8 (173.9e177.8) 45.5 (45.0e46.0) 99.9 (98.3e101.4) 152.8 (148.5e157.2) 182.2 (179.6e184.9) 51.3 (50.5e52.2) 104.6 (102.4e106.8) 132.0 (127.1e136.9)
90e100/80e90 cm 184.5 (182.3e186.8) 44.9 (44.3e45.5) 105.8 (103.9e107.6) 172.2 (167.1e177.2) 185.7 (183.5e187.9) 51.2 (50.5e51.9) 106.2 (104.3e108.1) 142.3 (138.2e146.5)
>100/90 cm 185.5 (181.8e189.1) 43.8 (42.9e44.8) 108.0 (105.0e111.0) 168.2 (160.1e176.3) 188.4 (185.8e191.0) 50.0 (49.2e50.8) 107.7 (105.5e109.9) 152.8 (148.0e157.6)
p value (ANOVA) <0.001 0.126 0.001 <0.001 <0.001 0.155 0.005 <0.001
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Fig. 2 e Prevalence, awareness, treatment and control of
hypercholesterolemia in the study subjects (age-adjusted
percent values among as subjects with total cholesterol
‡200 mg/dl).
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 8 0e2 8 8 287had borderline high total cholesterol and 9% had high total
cholesterol. Among those with borderline and high choles-
terol the proportion of men and women, respectively, who
were aware, treated, and controlled, was 8.8% and 7.5%, 3.5%
and 3.4%, and 1.9% and 1.5%. Another study in China35 which
evaluated 46,239 adults, the prevalence of borderline and high
total cholesterol was 32% and awareness, treatment, and
control were 11.0%, 5.1%, and 2.8%, respectively. These rates
are similar to the present study, which shows a low status of
awareness, treatment and control of hypercholesterolemia
among the urban Asian Indian subjects. On the other hand, in
USA, the 1999e2000 NHANES reported that in men and
women with borderline high cholesterol (200 mg/dl), 34.8%
and 35.4% were aware that they had hypercholesterolemia,
14.0% and 10.2% were on treatment, and 7.5% and 3.7% had
cholesterol >200 mg/dl.10 Another study reported that in USA
between 1988e1994 and 1999e2004 the awareness of hyper-
cholesterolemia increased from 39.2% to 63.0%, use of phar-
macologic lipid-lowering treatment increased from 11.7% to
40.8% and LDL cholesterol control increased from 4.0% to
25.1% in those with high LDL cholesterol.36 The present study,
thus, indicates a substantial gap in awareness, treatment and
control for hypercholesterolemia in India.
This study has a few limitations. We did not study pop-
ulations in all the Indian states, however, inclusion of all the
regions of India is unique. Sampling confined to urban loca-
tions in middle-level cities could be criticized for selection
bias, however, such urban locations now represent the heart
of India19 and is a fertile ground for cardiovascular epidemic.
Moreover, rapidly increasing urbanization in the country shall
lead to more than 60% of the population shall be in similar
locations within the next 20e30 years.22 The study, therefore,
illustrates the need to create more healthy cities for control of
atherogenic lipid abnormalities.37 Thirdly, the data from
middle-class locations in urban areas may not be generaliz-
able to the whole country. Almost 30% of Indian population
live in urban slums and more than 65% dwell in rural loca-
tions. However, the study does provide a snapshot on more
than 300 million Indians who are middle class and provides a
glimpse into the future of the country.19 Fourthly, theINTERHEART study reported that high ratio of apo B to apo A is
a more important lipid risk factor in South Asian subjects.38
We did not study these apolipoproteins. The predictive value
of standard dyslipidemias, evaluated in the present study, vis
a vis abnormal apolipoproteins should be prospectively stud-
ied in India before the latter are widely adopted.
In conclusion thismultisite survey among urban population
in India shows that although total cholesterol and LDL choles-
terol levels are low among Asian Indian men and women, tri-
glyceride levels are high and similar to Caucasian and Chinese
populations. Components of atherogenic dyslipidemias
(borderline high LDL cholesterol, low HDL cholesterol and high
triglycerides) are the most prevalent lipid abnormalities. Very
low awareness, treatment and control rates for hypercholes-
terolemia in this literate middle-class urban population in-
dicates significant gaps inpreventionof cardiovascular diseases
in the country. Large scale public health interventions are
required to increase awareness and management of lipid ab-
normalities to control these dyslipidemias.Authors’ contributions
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